Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 1.443
Filtrar
1.
Mol Med Rep ; 24(5)2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34505634

RESUMO

Gastritis refers to inflammation caused by injury to the gastric epithelium, which is usually due to excessive alcohol consumption and prolonged use of nonsteroidal anti­inflammatory drugs. Millions of individuals worldwide suffer from this disease. However, the lack of safe and promising treatments makes it urgent to explore and develop leads from natural resources. Therefore, food as medicine may be the best approach for the treatment of these disorders. The present study described the protective effects of food­polydeoxyribonucleotides (f­PDRNs) in a rat model of gastric mucosal injury induced by HCl­EtOH. Administration of f­PDRN was performed with low­PRF002 (26 mg/kg/day), medium­PRF002 (52 mg/kg/day) and high­PRF002 (78 mg/kg/day) on the day of autopsy. The site of damage to the mucous membrane was also analysed. In addition, an increase in gastric juice pH, total acidity of gastric juice and decrease in gastric juice secretion were confirmed, and gastric juice secretion­related factors corresponding to the administration of f­PDRN were analysed. Administration of f­PDRN reduced the mRNA expression of histamine H2 receptor, muscarinic acetylcholine receptor M3, cholecystokinin 2 receptor and H+/K+ ATPase related to gastric acid secretion and downregulation of histamine, myeloperoxidase and cyclic adenosine monophosphate. In addition, it was histologically confirmed that the loss of epithelial cells and the distortion of the mucosa were recovered in the group in which f­PDRN was administered compared to the model group with gastric mucosa damage. In summary, the present study suggested that f­PDRN has therapeutic potential and may have beneficial effects if taken regularly as a food supplement.


Assuntos
Mucosa Gástrica/metabolismo , Gastrite/tratamento farmacológico , Polidesoxirribonucleotídeos/farmacologia , Consumo de Bebidas Alcoólicas/efeitos adversos , Animais , AMP Cíclico/metabolismo , Modelos Animais de Doenças , Etanol/efeitos adversos , Alimentos , Suco Gástrico/química , Suco Gástrico/efeitos dos fármacos , Mucosa Gástrica/lesões , Histamina/metabolismo , Masculino , Polidesoxirribonucleotídeos/metabolismo , Ratos , Ratos Sprague-Dawley
2.
Turk J Gastroenterol ; 32(1): 53-65, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33893766

RESUMO

OBJECTIVE: To evaluate the diagnostic efficacy of gastric juice-based genotypic methods for Helicobacter pylori detection and antibiotic resistance testing. METHODS: We used electronic databases including Medline, Embase, Web of Science and the Cochrane Central Register of Controlled Trial for literature survey using keywords such as "gastric juice", "Helicobacter pylori" and their synonyms. The quality of the studies was assessed using QUADAS-2. Summary performance measures (sensitivity, specificity, positive predictive values, negative predictive values, diagnostic odds ratio, and area under the summary receiver operating characteristic curve) and HSROC curves were produced. In addition, fagan plots were applied to illustrate the relationship among the prior test probability, PLR/NLR, and posterior test probability. RESULTS: Our study cohort comprised eight studies with 1235 participants (617 participants of H. pylori infection and 618 participants of non-H. pylori infection). Pooled sensitivity and specificity with a corresponding 95% confidence interval (CI) of gastric juice-based genotypic methods reflected values of 94% (95%CI, 86% - 98%) and 98% (95%CI, 85% - 100%), respectively. The global sensitivity and specificity of clarithromycin resistance were 92% (95%CI, 85% - 96%) and 90% (95%CI, 80% - 95%), respectively. CONCLUSION: Gastric juice-based genotypic methods can be used for diagnostic prediction of H. pylori infection as well as clarithromycin resistance testing.


Assuntos
Suco Gástrico , Infecções por Helicobacter , Helicobacter pylori , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Claritromicina/farmacologia , Claritromicina/uso terapêutico , Resistência Microbiana a Medicamentos/efeitos dos fármacos , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/microbiologia , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Infecções por Helicobacter/genética , Infecções por Helicobacter/microbiologia , Helicobacter pylori/genética , Helicobacter pylori/isolamento & purificação , Humanos , Testes de Sensibilidade Microbiana , Técnicas Microbiológicas
3.
Carbohydr Polym ; 254: 117415, 2021 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-33357899

RESUMO

Grapefruit peel nanofibrillated cellulose (GNFC) was used as fat substitute in ice cream. GNFC was characterized by TEM, SEM, and XRD. The effects of GNFC on textural profiles, rheological properties, melting resistance, sensory properties, microstructure, and gross energy (GE) of ice cream were investigated. The results showed that GNFC was short rod-shaped crystal. Ice cream added with GNFC exhibited elastic-dominated behavior and better textural properties. The sensory evaluation score reached the highest level with desirable three-dimensional network structure at 0.4 % GNFC addition. GE of ice cream significantly decreased with reducing fat with maximal reduction rate of 17.90 %. Furthermore, the results of in vitro simulated digestion showed that GNFC addition and fat reduction significantly inhibited fat digestibility of ice cream due to coalescence of fat droplets on GNFC. This study provides new sustainable perspectives for the application of GNFC prepared from agricultural waste as fat substitute in food products.


Assuntos
Celulose/química , Citrus paradisi/química , Substitutos da Gordura/química , Sorvetes , Nanofibras/química , Nanopartículas/química , Extratos Vegetais/química , Celulose/farmacologia , Óxidos N-Cíclicos/química , Digestão/efeitos dos fármacos , Elasticidade , Substitutos da Gordura/farmacologia , Ácidos Graxos não Esterificados/química , Manipulação de Alimentos/métodos , Congelamento , Suco Gástrico/química , Suco Gástrico/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Leucina/química , Extratos Vegetais/farmacologia , Reologia/métodos , Paladar
4.
Carbohydr Polym ; 251: 117111, 2021 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-33142648

RESUMO

In this study, the resveratrol was nano-encapsulated in three different sources of starch like Water chestnut Horse chestnut and Lotus stem to safeguard it from gastric conditions and to improve its bioavailability and bioactivity upon digestion. The nano-capsules were prepared using safe and eco-friendly ultra-sonication method and studied for encapsulation-efficiency, particle-size and zeta-potential measurement. These were also characterized by ATR-FTIR, SEM, XRD and DSC. The release behaviour of resveratrol and its activity against anti-diabetic and anti-obesity were also studied. The particle size of HSR, LSR and WSR was found to be 419, 797 and 691 nm with a zeta potential of -16.09, -24.28 and -14.77 and encapsulation efficiency of 81.46, 75.83 and 79.37 %, respectively. The nanoparticles showed porous or film-like structures with decreased crystallinity and higher transition temperatures. The maximum percentage of resveratrol was released in intestinal juice and exhibited higher anti-obesity and anti-diabetic activities than free resveratrol after digestion.


Assuntos
Nanocápsulas/química , Resveratrol/química , Resveratrol/farmacologia , Amido/química , Antioxidantes/química , Antioxidantes/farmacocinética , Antioxidantes/farmacologia , Liberação Controlada de Fármacos , Suco Gástrico/efeitos dos fármacos , Humanos , Lipase/antagonistas & inibidores , Lipase/metabolismo , Nanopartículas/química , Tamanho da Partícula , Resveratrol/farmacocinética , Esterol Esterase/antagonistas & inibidores , Esterol Esterase/metabolismo , Ultrassom , alfa-Glucosidases/química
5.
Arch Microbiol ; 203(1): 183-191, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-32803345

RESUMO

In this study, the presence of plasmids responsible for carbohydrate fermentation and antibiotic resistance and the stability of these plasmids in artificial gastric juice were investigated in 20 Lactobacillus plantarum strains with probiotic properties. Plasmid curing was performed with novobiocin, acriflavine and elevated incubation temperature to identify plasmids encoded with carbohydrate fermentation and antibiotic resistance genes and to compare them with artificial gastric juice. Plasmid profiling of the strains revealed that 100% of the strains were harbouring plasmids in varying sizes and numbers. The plasmid number of the potential probiotic strains ranged between 1 and 4, and the plasmid size ranged between 5.779 and 16.138 kb. The potential probiotic strains could not survive in the artificial gastric juice at pH 2.0. Although the strains maintained their viability in an artificial gastric juice at pH 2.5 and 3.0, and their derivatives lost their plasmids at a high rate (100%). Similarly, high levels of cured derivatives were obtained with 8 µg/mL novobiocin and 100 µg/mL acriflavine applications, and 24 h incubation at 43 °C. All the experiments were also performed to compare with two L. plantarum-type strains containing plasmids responsible for tetracycline and tetracycline + erythromycin resistances. Artificial gastric juice and other plasmid curing treatments caused a high-frequency loss in the antibiotic resistances of type strains. Determining plasmid stability in artificial gastric juice is a novel approach. Plasmid stability in the gastrointestinal tract is important for maintaining the plasmid-encoded probiotic properties.


Assuntos
Acriflavina/farmacologia , Farmacorresistência Bacteriana/genética , Suco Gástrico/microbiologia , Lactobacillus plantarum/efeitos dos fármacos , Novobiocina/farmacologia , Antibacterianos/farmacologia , Fermentação , Suco Gástrico/efeitos dos fármacos , Temperatura Alta , Lactobacillus plantarum/genética , Plasmídeos/genética , Probióticos , Resistência a Tetraciclina/genética
6.
Food Chem ; 338: 127825, 2021 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-32810814

RESUMO

Four soluble dietary fibers (SDFs) were fortified with corn starch (CS) at different concentrations to match the same viscosity equivalents. The mixtures were subjected to a simulated digestion procedure to study the effects of SDFs on viscosity properties and digestion kinetics of CS. Results showed that SDFs increased the hydration property and decreased the water mobility of digesta. During digestion process, SDFs increased the apparent viscosity of digesta to some extent, and showed significant difference to delay the decay of digesta viscosity (kv). The amylolysis inhibitory ability was similar when each SDF was present at the same viscosity equivalent, however, significant differences were found on the digestion rate constant of k2. Linear correlations between kv and k2 were established for 1 and 2 equivalent groups. These results demonstrated that SDFs could delay the digestion process as chemistry differences, which related to their ability on delaying the change of digesta viscosity.


Assuntos
Fibras na Dieta/farmacologia , Amido/química , Amido/farmacocinética , Animais , Digestão , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Cinética , Mananas/química , Polissacarídeos/química , Polissacarídeos Bacterianos/química , Solubilidade , Viscosidade
7.
Molecules ; 25(23)2020 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-33260419

RESUMO

Inulae Flos, the flower of Inula britannica L., is used as a dietary supplement, beverage, and medicine in East Asia. In this study, we evaluated the gastroprotective effects of Inulae Flos extract (IFE) against gastric mucosal lesions induced by hydrochloric acid (HCl)/ethanol in rats and explored its potential mechanisms by measuring antioxidant enzyme activity, mucus secretion, and prostaglandin E2 (PGE2) levels. Pretreatment with IFE at doses of 100 and 300 mg/kg significantly inhibited gastric lesions in HCl/ethanol-treated rats. IFE increased the activities of superoxide dismutase and catalase and the levels of glutathione and PGE2 in gastric tissues. The administration of IFE also significantly increased the gastric wall mucus contents in HCl/ethanol-induced gastric lesions. These findings suggest that IFE has gastroprotective effects against HCl/ethanol-induced gastric lesions and exerts these effects through increased antioxidant levels and gastric mucus secretion. Inulae Flos may be a promising agent for the prevention and treatment of gastritis and gastric ulcers.


Assuntos
Flores/química , Inula/química , Extratos Vegetais/farmacologia , Substâncias Protetoras/farmacologia , Úlcera Gástrica/tratamento farmacológico , Animais , Antioxidantes/metabolismo , Catalase/metabolismo , Dinoprostona/metabolismo , Modelos Animais de Doenças , Etanol/toxicidade , Suco Gástrico/efeitos dos fármacos , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/patologia , Glutationa Peroxidase/metabolismo , Ácido Clorídrico/toxicidade , Masculino , Malondialdeído/metabolismo , Muco/metabolismo , Extratos Vegetais/administração & dosagem , Substâncias Protetoras/administração & dosagem , Ratos Sprague-Dawley , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/patologia , Superóxido Dismutase/metabolismo
8.
Regul Toxicol Pharmacol ; 117: 104754, 2020 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32777432

RESUMO

The oral bioaccessibility of copper alloys and pure metals was assessed using in vitro methods with synthetic saliva and gastric fluid. The metal-specific migration rates from polished alloy surfaces are higher in gastric (pH 1.5) than in saliva fluid (pH 7.2). In both media, migrations are higher for lead than for other metals. The bioaccessible metal concentrations in massive copper alloys, after 2 h in gastric fluid, was only <0.01%-0.18%, consistent with the low surface reactivity of copper alloys (defined as 1 mm spheres). The average metal-specific migrations of cobalt, copper, nickel and lead from most of the tested copper alloys in gastric media are comparable to the ones from their pure metals. The data further show that the bioaccessibility of metals in massive copper alloys primarily depends on the bioelution medium, the exposed surface area and the composition of the alloy. The tested copper alloys show only limited evidence for influence of alloy surface microstructure. This is contrary to findings for other alloys such as stainless steel. Additional investigations on other copper alloys could allow to further refine these conclusions. These findings are useful for establishing the hazard and risk profile of copper alloys following oral exposure.


Assuntos
Ligas/análise , Cobre/análise , Suco Gástrico/química , Saliva/química , Ligas/metabolismo , Animais , Disponibilidade Biológica , Cobre/metabolismo , Migração de Corpo Estranho/metabolismo , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Humanos , Saliva/efeitos dos fármacos , Saliva/metabolismo , Suínos
9.
J Ethnopharmacol ; 257: 112825, 2020 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-32320728

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Semen Arecae (SA) is one of the most commonly used Traditional Chinese Medicine. Charred Semen Arecae (CSA) is the processed product of SA. Alkaloids are considered as pharmacological mechanisms of SA and CSA on gastrointestinal motility. Recent studies have shown alkaloids decreased quickly after procession. However, the promoting on gastrointestinal motility were not decreased. Is gastrointestinal motility related to alkaloids of CSA? This study explored the effects of SA, CSA, Semen Arecae-Removal (SA-R), and Charred Semen Arecae-Removal (CSA-R) on gastrointestinal motility, Gastric Inhibitory Polypeptide (GIP), Glucagon Like Peptide-1 (GLP-1), gastric juice and bile in rats. MATERIAL AND METHODS: Rats were randomly divided into six groups, including the Control group, SA group, CSA group, SA-R group, CSA-R group, and Positive drug group (Mosapride). Alkaloids of samples were knocked out by using the "target constituent removal" strategy. Gastric residue and intestinal propulsion rate were evaluated in rats. Serum levels of GIP and GLP-1 were measured by Enzyme-Linked Immunosorbent Assay (ELISA). Gastric juice and bile were examined, respectively. RESULTS: CSA-R and SA-R have been investigated by the Preparative Thin-layer Chromatography (PTLC) method. Intestinal propulsion and gastric residue assessments confirmed the effectiveness of CSA and CSA-R. CSA-R was higher than SA-R in the GLP-1, pepsin activity, the secretion of bile, Bilirubin (BIL), and Cholesterol (CHO). The statistical comparison demonstrated that there is no difference between the CSA group and CSA-R group. CONCLUSIONS: After processing, the promoting gastrointestinal motility might be not related to alkaloids. Maillard reaction could be produced to promote the secretion of GLP-1, bile, and CHO for gastrointestinal motility. Our findings provide a pharmacological reference for the clinical application of SA and CSA in the treatment of digestive diseases.


Assuntos
Alcaloides/farmacologia , Areca , Medicamentos de Ervas Chinesas/farmacologia , Motilidade Gastrointestinal/efeitos dos fármacos , Animais , Bile/efeitos dos fármacos , Polipeptídeo Inibidor Gástrico/análise , Polipeptídeo Inibidor Gástrico/sangue , Polipeptídeo Inibidor Gástrico/metabolismo , Suco Gástrico/efeitos dos fármacos , Peptídeo 1 Semelhante ao Glucagon/sangue , Peptídeo 1 Semelhante ao Glucagon/metabolismo , Ratos , Ratos Sprague-Dawley
10.
Int J Nanomedicine ; 15: 601-618, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32099354

RESUMO

PURPOSE: The purpose of this research was to study the basic physicochemical and biological properties regarding the application of L-tartaric acid modified chiral mesoporous silica nanoparticle (CMSN) as a drug carrier, and to explore the structure-property relationship of silica-based materials. METHODS: CMSN with functions of carboxyl modification and chirality was successfully synthesized through co-condensation method, and the basic characteristics of CMSN, including morphology, structure, wettability, degradation, bio-adhesion and retention ability in gastrointestinal tract (GI tract) were estimated by comparing with non-functionalized mesoporous silica nanoparticles (MSN). Meanwhile, the biocompatibility and toxicity of L-tartaric modification were systematically evaluated both in vitro and in vivo through MTT cell viability assay, cell cycle and apoptosis assay, hemolysis assay, histopathology examination, hematology analysis, and clinical chemistry examination. RESULTS: CMSN and MSN were spherical nanoparticles with uniform mesoporous structure. CMSN with smaller pore size and carboxyl functional groups exhibited better wettability. Besides, CMSN and MSN could dissolve thoroughly in simulated physiological fluids during a degradation period of 1-12 weeks. Interestingly, the in vitro and in vivo behaviors of carriers, including degradation, bio-adhesion and retention ability in the GI tract were closely related to wettability. As expected, CMSN had faster degradation rate, higher mucosa-adhesion ability, and longer retention time. Particularly, CMSN improved the bio-adhesion property in both gastric mucosa and small intestinal mucosa, and prolonged the GI tract retention time to at least 12 h, which meant higher probability for absorption. The biocompatibility and toxicity examination indicated that CMSN was a kind of biocompatible bio-material with good blood compatibility and negligible toxicity, which is required for further applications in biological fields. CONCLUSION: CMSN with functions of carboxyl modification and chirality had superiority in terms of both physicochemical and biological properties. The in vitro and in vivo behaviors of carriers, including degradation, bio-adhesion, and retention were closely related to wettability.


Assuntos
Portadores de Fármacos/química , Portadores de Fármacos/farmacocinética , Nanopartículas/química , Tartaratos/química , Animais , Apoptose/efeitos dos fármacos , Materiais Biocompatíveis , Linhagem Celular , Sobrevivência Celular , Dicroísmo Circular , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Trato Gastrointestinal/efeitos dos fármacos , Trato Gastrointestinal/metabolismo , Hemólise/efeitos dos fármacos , Humanos , Teste de Materiais , Microscopia Eletrônica de Transmissão , Nanopartículas/metabolismo , Coelhos , Ratos Sprague-Dawley , Dióxido de Silício/química , Espectroscopia de Infravermelho com Transformada de Fourier , Relação Estrutura-Atividade , Molhabilidade
11.
Aliment Pharmacol Ther ; 51(5): 534-543, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31990424

RESUMO

BACKGROUND: Vonoprazan (V), a potassium-competitive acid blocker, has a more durable acid-inhibitory effect as compared with standard-dose proton pump inhibitors (PPIs) but has not been compared with 2-4 times higher daily PPI doses administered in two divided doses. AIMS: To evaluate the acid-inhibitory effect of V 10/20 mg once-daily (OD; V10/V20) vs rabeprazole (R) 10/20 mg twice-daily (BID; R20/R40) in healthy Japanese volunteers. METHODS: This multicentre, randomised, open-label, two-period, crossover study compared V10 or V20 vs R20, or V20 vs R40 using three cohorts of 10 healthy Japanese adults. Within each cohort, subjects were randomised to receive V or R for 7 days and, following a washout period ≥7 days, the other treatment for 7 days. On day 6 of each period, 24-hours multichannel gastric impedance-pH monitoring was performed. Percent times pH ≥ 3, ≥4 and ≥5 (pH 3, 4 and 5 holding time ratios [HTRs]) in 24 hours were evaluated as primary pharmacodynamic endpoints. RESULTS: Acid-inhibitory effect (24-hours pH 3 HTR) of V20 was greater than those of R20 (91.0% vs 65.3%; P = .0049) and R40 (98.5% vs 85.9%; P = .0073). Similar results were obtained for 24-hours pH 4 and 5 HTRs. V20 also achieved greater nocturnal pH 4 (91.5% vs 73.2%; P = .0319) and 5 HTRs (78.8% vs 62.2%; P = .0325) as compared with R40. One subject (20%) developed diarrhoea while receiving R40 which was considered treatment-related. CONCLUSIONS: Compared with 2-4 times the standard daily dose of R, V20 exerts a more potent and durable acid-inhibitory effect. Trial identifier: UMIN000022198 (www.umin.ac.jp/ctr/index.htm).


Assuntos
Antiácidos/administração & dosagem , Ácido Gástrico/metabolismo , Suco Gástrico/efeitos dos fármacos , Inibidores da Bomba de Prótons/administração & dosagem , Pirróis/administração & dosagem , Rabeprazol/administração & dosagem , Sulfonamidas/administração & dosagem , Adolescente , Adulto , Antiácidos/efeitos adversos , Estudos Cross-Over , Relação Dose-Resposta a Droga , Esquema de Medicação , Feminino , Suco Gástrico/metabolismo , Voluntários Saudáveis , Humanos , Concentração de Íons de Hidrogênio , Japão , Masculino , Polimorfismo Genético , Inibidores da Bomba de Prótons/efeitos adversos , Pirróis/efeitos adversos , Rabeprazol/efeitos adversos , Sulfonamidas/efeitos adversos , Adulto Jovem
12.
Drug Des Devel Ther ; 14: 5721-5734, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33408461

RESUMO

AIM: Lactobacillus fermentum XY18 (LF-XY18) is a bacterial strain with satisfactory antioxidant properties in vitro that we previously isolated from Xinjiang yogurt. This article will explore the preventive effect of LF-XY18 on acute gastric injury and provide the basis for the innovative development and application of lactic acid bacteria (LAB). METHODS: Kunming mice underwent gastric injury induced by hydrochloric acid and ethanol. LF-XY18 isolated from yogurt in Xinyuan County in the Yili region of Xinjiang was subsequently administered intragastrically to mice for 2 weeks to explore the mechanism of LF-XY18 in preventing gastric injury via its antioxidant effects. RESULTS: There was decreased gastric juice volume, gastric injury area, and formation of gastric mucosal lesions in the LF-XY18 mice as compared to those in the control mice, while LF-XY18 prevented the decrease in the gastric juice pH value in mice. Compared with the gastric injury model group mice, LF-XY18 reduced the serum levels of motilin, substance P, interleukin-6, interleukin-12, tumor necrosis factor-α, and interferon-γ but increased the serum levels of somatostatin and vasoactive intestinal peptide. The activities of superoxide dismutase, glutathione peroxidase, glutathione, and nitric oxide were increased in the gastric tissue of the LF-XY18 mice compared with the control mice, but malondialdehyde activity was decreased in the LF-XY18 mice. Quantitative polymerase chain reaction analysis illustrated that in the gastric tissue of LF-XY18 mice, the messenger RNA (mRNA) expression of occludin, epidermal growth factor (EGF), EGF receptor, vascular EGF, inhibitor kappa-B-α, neuronal nitric oxide synthase, endothelial nitric oxide synthase, cuprozinc superoxide dismutase, manganese superoxide dismutase, and catalase was stronger than that in the control mice, but the mRNA expression of activated B cells (NF-κB), inducible nitric oxide synthase, and cyclooxygenase-2 was weaker than in the control mice. CONCLUSION: These results indicate that LF-XY18 has a potential role in the prevention of gastric injury through antioxidant effects, and a high concentration (1.0 × 109 CFU/kg b.w.) of LF-XY18 has a stronger anti-gastric injury effect than a low concentration (1.0 × 108 CFU/kg b.w.).


Assuntos
Antioxidantes/farmacologia , Gastrite/prevenção & controle , Limosilactobacillus fermentum/isolamento & purificação , Administração Oral , Animais , Antioxidantes/administração & dosagem , Modelos Animais de Doenças , Etanol , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Gastrite/induzido quimicamente , Gastrite/metabolismo , Ácido Clorídrico , Masculino , Camundongos , Camundongos Endogâmicos
13.
Int J Mol Sci ; 20(23)2019 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-31795477

RESUMO

Gastric juice is a unique combination of hydrochloric acid (HCl), lipase, and pepsin. Acidic gastric juice is found in all vertebrates, and its main function is to inactivate microorganisms. The phylogenetic preservation of this energy-consuming and, at times, hazardous function (acid-related diseases) reflects its biological importance. Proton pump inhibitors (PPIs) are one of the most widely used drugs in the world. Due to the reduced prevalence of Helicobacter pylori infection as well as the increased use of inhibitors of gastric acid secretion, the latter has become the most important cause of gastric hypoacidity. In the present manuscript, we review the microbiological consequences of removing gastric acidity. The resulting susceptibility to infections has not been studied extensively, and focus has mainly been restricted to bacterial and parasitic agents only. The strongest evidence concerning the relationship between hypochlorhydria and predisposition to infections relates to bacterial infections affecting the gastrointestinal tract. However, several other clinical settings with increased susceptibility to infections due to inhibited gastric acidity are discussed. We also discuss the impact of hypochlorhydria on the gut microbiome.


Assuntos
Acloridria/induzido quimicamente , Ácido Gástrico/metabolismo , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/microbiologia , Inibidores da Bomba de Prótons/efeitos adversos , Acloridria/complicações , Acloridria/metabolismo , Animais , Infecções Bacterianas/etiologia , Suco Gástrico/metabolismo , Gastroenteropatias/etiologia , Microbioma Gastrointestinal/efeitos dos fármacos , Humanos , Infecções/etiologia , Inibidores da Bomba de Prótons/farmacologia
14.
Sci Rep ; 9(1): 3559, 2019 03 05.
Artigo em Inglês | MEDLINE | ID: mdl-30837505

RESUMO

Sucralfate is effective for the treatment of gastric and duodenal ulcers owing to its protective gel-forming ability. However, the mechanism by which sucralfate protects the oesophageal mucosa against reflux oesophagitis has not been clarified. We aimed to investigate the mechanisms of action of sucralfate and sucrose octasulfate (SOS), a component of sucralfate. SOS and sucralfate were administered to oesophagitis-induced rats, and the ulcer lesion size was macroscopically examined and scored. Effective pepsin activity in the gastric juices obtained from the animal model was evaluated by a casein digestion test. Sucralfate and SOS improved the pathology scores in a dose-dependent manner, whereas gastric juice pepsin activity was not impaired by therapeutic doses of SOS. As SOS lacks the ability to form a thick gel layer by polymerisation, we examined the distribution of SOS in the mucosal lumen by imaging mass spectrometry (IMS) to determine whether SOS directly adheres to the mucosal surface. A clear homogeneous thin-layer SOS film (>100 µm thick) was visualized on the oesophageal mucosal surface. Moreover, this SOS film formation was enhanced at ulcer lesion sites. Taken together, SOS appears to protect oesophageal mucosa against reflux oesophagitis via thin-layer formation on the mucosal surface.


Assuntos
Mucosa Esofágica/efeitos dos fármacos , Esofagite Péptica/prevenção & controle , Sacarose/análogos & derivados , Animais , Mucosa Esofágica/metabolismo , Mucosa Esofágica/patologia , Esofagite Péptica/complicações , Esofagite Péptica/metabolismo , Esofagite Péptica/patologia , Suco Gástrico/efeitos dos fármacos , Masculino , Úlcera Péptica/complicações , Ratos , Ratos Sprague-Dawley , Sacarose/metabolismo , Sacarose/farmacologia
15.
Int J Biol Macromol ; 123: 300-307, 2019 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-30445072

RESUMO

Gel microparticles were prepared from pectins of campion (SVCgel) and duckweed (LMCgel) callus cultures, as well as from commercial apple pectin (APgel) by emulsion dehydration techniques with successive ionotropic gelation. The morphology and swelling behavior of the microparticles were determined after successive incubation in simulated gastric (SGF), intestinal (SIF), and colonic (SCF) fluids. Both SVCgel and LMCgel microparticles were found to swell in SGF and SIF gradually, and at oral administration decreased food intake by laboratory mice during the first 5 h of free-feeding. The SVCgel microparticles demonstrated the higher stability in SCF within 24 h than LMCgel ones. Only the SVCgel microparticles were shown to decrease food intake by 24% during the 21 h of free-feeding and decreased body weight of mice by 4% during 24 h after oral administration. The APgel microparticles lost their shape in SIF, then fully disintegrated after 0.5 h of incubation in SCF, and failed to affect food intake or mice body weight. The data obtained indicated that sustainability and swelling of the gel microparticles from the SVC pectin in the colonic fluid may provide the stronger satiating effect compared to that of the LMCgel microparticles.


Assuntos
Líquidos Corporais/efeitos dos fármacos , Calo Ósseo/química , Ingestão de Alimentos/efeitos dos fármacos , Pectinas/administração & dosagem , Administração Oral , Animais , Colo/efeitos dos fármacos , Portadores de Fármacos , Edema/tratamento farmacológico , Emulsões/administração & dosagem , Emulsões/química , Suco Gástrico/efeitos dos fármacos , Humanos , Intestinos/efeitos dos fármacos , Malus/química , Camundongos , Tamanho da Partícula , Pectinas/química , Células Vegetais/química
16.
J Sep Sci ; 42(3): 678-683, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30488564

RESUMO

Paracetamol is a widely used drug for fever and pain relief. Ibuprofen is a common nonsteroidal anti-inflammatory drug. In this study, a sensitive and accurate reversed phase high performance liquid chromatography method was developed for the simultaneous determination of ibuprofen and paracetamol. The chromatographic separation was achieved on a Phenomenex C18 (250 mm, 4.6 mm, 5 µm) column. Fifty milli molar phosphate buffer (pH 7.5) and methanol were used as mobile phase in a gradient elution mode. The retention times of paracetamol and ibuprofen were 5.7 and 10.4 min, respectively. The linearity of the developed method was established in the range of 0.25 - 250 mg/L with a correlation coefficient of 0.9998 for both analytes. The limit of detection/quantification values were found to be 0.06/0.19 and 0.08/0.26 mg/L for ibuprofen and paracetamol, respectively. The method was successfully applied in drug samples in the form of tablets and suspensions. The calculated concentrations matched with the claimed values on their prospectuses. The drug samples were studied under simulated gastric conditions to determine the behaviors of the analytes in the human body. The obtained results showed no change in the retention time of the analyte peak shapes throughout the 210 minutes.


Assuntos
Acetaminofen/análise , Acetaminofen/farmacologia , Suco Gástrico/efeitos dos fármacos , Ibuprofeno/análise , Ibuprofeno/farmacologia , Estômago/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Humanos , Comprimidos , Fatores de Tempo
17.
J Nat Med ; 73(2): 339-352, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30523551

RESUMO

The aim of this study was to elucidate the gastroprotective activity and possible mechanism of involvement of araloside A (ARA) against ethanol- and aspirin-induced gastric ulcer in mice. The experimental mice were randomly divided into control, model, omeprazole (20 mg/kg, orally) and ARA (10, 20 and 40 mg/kg, orally). Gastric ulcer in mice was induced by intragastric administration of 80% ethanol (10 mL/kg) containing 15 mg/mL aspirin 4 h after drug administration on day 7. The results indicated that ARA could significantly raise gastric juice volume and acidity; ameliorate gastric mucosal blood flow, gastric binding mucus volume, ulcer index and ulcer inhibition rate; suppress H+/K+-ATPase activity, which was confirmed by computer-aided docking simulations; inhibit the release of mitochondrial cytochrome c into the cytoplasm; inhibit caspase-9 and caspase-3 activities and down-regulate mRNA expression levels; down-regulate the mRNA and protein expressions of apoptosis protease-activating factor-1 and protein expression of cleaved poly(ADP ribose) polymerase-1; and up-regulate Bcl-2 mRNA and protein expressions and down-regulate Bax mRNA and protein expressions, thus elevating the Bcl-2/Bax ratio in a dose-dependent manner. Histopathological observations further provided supportive evidence for the aforementioned results. The results demonstrated that ARA exerted beneficial gastroprotective effects on alcohol- and aspirin-induced gastric ulcer in mice, which was related to suppressing H+/K+-ATPase activity as well as pro-apoptotic protein expression, and promoting anti-apoptotic protein expression, thus alleviating gastric mucosal injury and cell death.


Assuntos
Antiulcerosos/uso terapêutico , Mucosa Gástrica/efeitos dos fármacos , ATPase Trocadora de Hidrogênio-Potássio/efeitos dos fármacos , Ácido Oleanólico/análogos & derivados , Saponinas/uso terapêutico , Úlcera Gástrica/prevenção & controle , Animais , Antiulcerosos/isolamento & purificação , Antiulcerosos/farmacologia , Fator Apoptótico 1 Ativador de Proteases/metabolismo , Aralia/química , Aspirina/efeitos adversos , Caspase 3/metabolismo , Caspase 9/metabolismo , Citocromos c/metabolismo , Avaliação Pré-Clínica de Medicamentos , Etanol/efeitos adversos , Suco Gástrico/efeitos dos fármacos , Mucosa Gástrica/irrigação sanguínea , Mucosa Gástrica/metabolismo , ATPase Trocadora de Hidrogênio-Potássio/metabolismo , Masculino , Camundongos , Mitocôndrias/metabolismo , Simulação de Acoplamento Molecular , Ácido Oleanólico/isolamento & purificação , Ácido Oleanólico/farmacologia , Ácido Oleanólico/uso terapêutico , Fitoterapia , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Poli(ADP-Ribose) Polimerase-1/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Distribuição Aleatória , Fluxo Sanguíneo Regional/efeitos dos fármacos , Saponinas/isolamento & purificação , Saponinas/farmacologia , Úlcera Gástrica/induzido quimicamente
18.
Molecules ; 23(12)2018 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-30513668

RESUMO

Hericium erinaceus (HE) is a well-known edible and medicinal fungus widely grown in Asian countries. Polysaccharides from the Hericium erinaceus (HEP) are major biological macromolecules. It has been reported that HEP has multiple biological activities, such as antioxidant activity, immunomodulatory effects, anti-inflammatory effect, anti-chronic gastritis activity, and so on. In the current study, we investigated the biological property of HEP during gastrointestinal digestion. The results indicated that both simulated gastric and small intestinal digesta of HEP has better stimulation of probiotics growth than HEP alone, especially for Lactobacillus plantarum BG112. The prebiotic activity was the strongest when HEP was treated by simulated gastric juice for 2 h and by simulated small intestinal juice for 4 h. The molecular weight (Mw) of HEP decreased from 1.68 × 106 Da and 2.32 × 104 Da to 529.3 ± 7.2 Da, as digestion time increased. Meanwhile, the reducing sugar content was significantly increased from 0.610 ± 0.007 to 22.698 ± 0.752 mg/ml, suggesting that the decrease of Mw was likely due to the breakdown of glycosidic bonds. Considerable mannose and galactopyranose were released throughout the gastrointestinal digestion period, indicating that the gastrointestinal digestion resulted in production of free monosaccharides. After fermentation of L. plantarum BG112, the Mw of HEP was decreased and short chain fatty acids (SCFAs) including acetic acid, isovaleric acid, lactic acid, and butyric acid were produced. We speculated that the release of free monosaccharides during gastrointestinal digestion and utilization of HEP, by the probiotics, contributed to the prebiotic activity of HEP's gastric and intestinal digesta. These results unveiled some mechanisms on the close relationship between the structure and bioactivity of polysaccharides, during digestion.


Assuntos
Basidiomycota/química , Intestinos/química , Polissacarídeos/farmacologia , Prebióticos , Estômago/química , Digestão , Ácidos Graxos/biossíntese , Fermentação , Cromatografia Gasosa-Espectrometria de Massas , Suco Gástrico/efeitos dos fármacos , Peso Molecular , Monossacarídeos/análise , Padrões de Referência
19.
Biomed Pharmacother ; 107: 90-95, 2018 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-30081206

RESUMO

OBJECTIVE: evaluate the antiulcer healing effect of echinochrome pigment (Ech 5 and 10 mg/kg) extracted from sea urchin (Paracentrotus lividus). METHODS: Severe gastric ulceration induced in rats by administration of indomethacin in combination with cold stress (IND + CS) for 2 h. The antiulcer effect of Ech was indicated by determination of gastric juice volume, gastric juice acidity, and ulcer index as well as determination of gastric malondialdhyde (MDA), glutathione (GSH), catalase (CAT), glutathione-S-transferase (GST), superoxide dismutase (SOD), nitric oxide (NO) activities. Moreover, macroscopic and microscopic evaluations of the stomachs were determined. RESULTS: The anti-ulcer healing effect of Ech against IND + CS induced oxidative tissue injury was investigated by a significant decrease in MDA level, GST and CAT activities and a significant increase of GSH content, NO level and SOD activity. In addition, Ech treatments (5 mg/kg and 10 mg/kg) reduce gastric lesion area to (73.51% and 75.50%, respectively) with great amelioration of the gastric juice volume and acidity. Also, affirmed by maintaining macroscopic and microscopic gastric mucosal integrity. CONCLUSIONS: Ech pigments had an insightful effect against peptic ulcer-induced oxidative stress in rats, as it alleviates the alterations in gastric acidity and ulcer index as well as the oxidative stress markers.


Assuntos
Naftoquinonas/uso terapêutico , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/tratamento farmacológico , Animais , Antioxidantes/farmacologia , Suco Gástrico/efeitos dos fármacos , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/patologia , Indometacina , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Naftoquinonas/farmacologia , Ratos Wistar , Úlcera Gástrica/patologia
20.
Pharmacol Rep ; 70(2): 390-397, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29397336

RESUMO

BACKGROUND: Prolonged use of aspirin, a commonly prescribed non steroidal anti-inflammatory drug, is well known to produce gastrointestinal toxicity which could be minimized by various anti-secretory agents. The present study was carried out to evaluate the protective effect of artesunate against aspirin induced gastric injury in rats. METHODS: Gastric injury was induced in fasted Wistar rats by oral administration of aspirin. The effect of 50 and 150mg/kg of artesunate was studied on macroscopic changes, gastric secretions, histology, oxidative stress and inflammatory markers in the stomach tissue after 5h of induction of gastric injury. Immunohistochemical analysis for the expression of IL-1ß, IL-6, NF-κB(p65) and COX-2 was also carried out. The effect of artesunate was compared with that of standard anti-ulcer drug famotidine (20mg/kg). RESULTS: Artesunate pretreatment produced a dose-dependent reduction in aspirin induced gastric injury and restored the gastric juice parameters. It normalized the tissue levels of oxidative stress markers (glutathione, malondialdehyde and superoxide dismutase activity) and mediators of inflammation (myeloperoxidase and TNF-α). The protection afforded by artesunate was evident from the histoarchitecture of stomach tissue and marked reduction in tissue expression of IL-1ß, IL-6, NF-κB(p65) and COX-2. The effect of artesunate was found to be comparable to that of standard drug famotidine. CONCLUSION: Artesunate markedly ameliorated aspirin induced gastric injury in rats by targeting oxidative stress and COX-2 dependent as well as COX-2 independent proinflammatory signaling pathways and could have a therapeutic potential in gastric ulcer disease.


Assuntos
Artemisininas/farmacologia , Aspirina/farmacologia , Inflamação/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Úlcera Gástrica/induzido quimicamente , Úlcera Gástrica/tratamento farmacológico , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Antiulcerosos/farmacologia , Artesunato , Ciclo-Oxigenase 2/metabolismo , Feminino , Suco Gástrico/efeitos dos fármacos , Suco Gástrico/metabolismo , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/metabolismo , Glutationa/metabolismo , Inflamação/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Masculino , Malondialdeído/metabolismo , Ratos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos , Úlcera Gástrica/metabolismo , Superóxido Dismutase/metabolismo , Fator de Transcrição RelA/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA